Outcomes of cardiac surgery in trisomy 18 patients

Jun Muneuchi1, Junko Yamamoto, Yasuhiko Takahashi

  • 1Department of Pediatrics, Kyushu Koseinenkin Hospital, Kishinoura, Yahatanishi-ku, Kitakyushu, Fukuoka, Japan. mune@pediatr.med.kyushu-u.ac.jp

Cardiology in the Young
|January 6, 2011
PubMed

Insights

Cardiac surgery in trisomy 18 patients improved survival rates but did not increase the likelihood of being discharged alive. Careful individualization of surgical indications is crucial for improving quality of life in these patients.

Area of Science:

  • Cardiology
  • Genetics
  • Pediatric Surgery

Background:

  • Trisomy 18 (Edwards syndrome) is a genetic disorder associated with severe congenital heart defects.
  • Outcomes for trisomy 18 patients with cardiac complications are often poor, necessitating evaluation of treatment strategies.

Purpose of the Study:

  • To investigate the impact of cardiac surgery on survival and discharge rates in patients with trisomy 18.
  • To identify factors influencing outcomes in this patient population.

Main Methods:

  • A retrospective analysis of 34 trisomy 18 patients with cardiac complications was performed.
  • Patients were categorized into surgical and conservative treatment groups.
  • Survival and alive discharge rates were compared between the two groups.

Main Results:

  • Cardiac surgery was performed on nine patients, with procedures including intracardiac repair, pulmonary arterial banding, and ductus ligation.
  • The surgery group demonstrated significantly higher cumulative survival rates at 1, 6, 12, and 24 months compared to the conservative group (p = 0.002).
  • However, there was no significant difference in the cumulative rates of discharge alive between the surgical and conservative groups.

Conclusions:

  • Cardiac surgery in trisomy 18 patients is associated with improved survival but not with a higher rate of discharge alive.
  • Hazardous factors for mortality included cardiac surgery itself and pre-operative assisted ventilation.
  • Individualized assessment for cardiac surgery is essential to enhance the quality of life for trisomy 18 patients.
Abstract

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...